Cargando…
Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells
The lipophilic statin lovastatin decreases cholesterol synthesis and is a safe and effective treatment for the prevention of cardiovascular diseases. Growing evidence points at antitumor potential of lovastatin. Therefore, understanding the molecular mechanism of lovastatin function in different cel...
Autores principales: | Kallas-Kivi, Ade, Trei, Annika, Maimets, Toivo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877483/ https://www.ncbi.nlm.nih.gov/pubmed/27247576 http://dx.doi.org/10.1155/2016/1580701 |
Ejemplares similares
-
SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium Butyrate
por: Kallas, Ade, et al.
Publicado: (2014) -
The role of integrin β1 in the heterogeneity of human embryonic stem cells culture
por: Kallas-Kivi, Ade, et al.
Publicado: (2018) -
Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
por: Kallas, Ade, et al.
Publicado: (2014) -
Nocodazole Treatment Decreases Expression of Pluripotency Markers Nanog and Oct4 in Human Embryonic Stem Cells
por: Kallas, Ade, et al.
Publicado: (2011) -
Changes in Laminin Expression Pattern during Early Differentiation of Human Embryonic Stem Cells
por: Pook, Martin, et al.
Publicado: (2015)